We have products in the pipeline based on our proprietary Photocure Technology® platform, within specialty areas such as acne and HPV and precancerous lesions of the cervix.
Cevira® is in development as a treatment for cervical persistent oncogenic human papilloma virus (HPV) infections and precancerous lesions. Selectively targeting the diseased area, Cevira® is a treatment modality aiming to preserve the competence of the cervix, an improvement over surgical procedures frequently used today.
Visonac® cream is Photocure's phase 3 ready product under development for
treatment of moderate to severe acne vulgaris